Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi Consumer Healthcare India Ltd

₹ 4,843 4.25%
31 Oct - close price
sanofi.in BSE: 544250 NSE: SANOFICONR
About

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]

Key Points

Business Overview:[1][2]
SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness

Website BSE NSE
  • Market Cap ₹ 11,153 Cr.
  • Current Price ₹ 4,843
  • High / Low ₹ 5,954 / 4,360
  • Stock P/E 56.4
  • Book Value ₹ 112
  • Dividend Yield 1.14 %
  • ROCE 111 %
  • ROE 83.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 43.4 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
210 160 222 172 160 171 173 221
116 97 140 109 97 109 109 151
Operating Profit 95 63 82 64 63 62 64 70
OPM % 45% 39% 37% 37% 39% 36% 37% 32%
1 3 3 -24 3 2 5 12
Interest 0 3 0 0 3 0 0 0
Depreciation 1 2 1 1 2 1 2 3
Profit before tax 95 61 84 39 61 63 67 79
Tax % 25% 26% 25% 25% 26% 29% 25% 23%
71 45 63 29 45 44 50 61
EPS in Rs 12.59 19.54 19.24 21.71 26.36
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2023 8m Dec 2024 TTM
555 724 724
337 454 465
Operating Profit 219 271 259
OPM % 39% 37% 36%
2 -15 22
Interest 0 4 5
Depreciation 2 4 8
Profit before tax 219 247 270
Tax % 25% 27%
165 181 200
EPS in Rs 78.59 86.85
Dividend Payout % 6% 70%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -2%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 84%

Balance Sheet

Figures in Rs. Crores

Dec 2023 Dec 2024 Jun 2025
Equity Capital 2 23 23
Reserves 206 250 234
0 20 28
138 138 137
Total Liabilities 345 431 422
5 29 42
CWIP 3 1 0
Investments 0 0 0
338 402 380
Total Assets 345 431 422

Cash Flows

Figures in Rs. Crores

Dec 2023 Dec 2024
-0 439
0 2
2 -116
Net Cash Flow 2 325

Ratios

Figures in Rs. Crores

Dec 2023 Dec 2024
Debtor Days 21 7
Inventory Days 232 80
Days Payable 144 138
Cash Conversion Cycle 109 -51
Working Capital Days 134 -33
ROCE % 111%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
60.40% 60.40% 60.40% 60.40% 71.27% 71.27%
6.03% 5.22% 4.42% 4.52% 3.24% 2.94%
22.60% 23.83% 25.35% 25.48% 16.89% 17.21%
10.98% 10.56% 9.84% 9.59% 8.59% 8.58%
No. of Shareholders 61,09158,58255,73451,85949,63248,808

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports